Bio-Rad Laboratories, Inc. Financials

Market Capitalization $9.85 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-16.26
Forward PE	30.26
Price to Sales TTM	$3.82
Price to Book MRQ	$1.32
Enterprise to Revenue	3.73
Enterprise to EBITDA	19.93

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-30.18%
Operating Margin	9.94%
Return on Assets TTM	1.86%
Return on Equity TTM	-9.79%

Income Statement

Revenue TTM	$2,580,208,896
Revenue per Share TTM	$90.82
Quarterly Revenue Growth	2.80%
Gross Profit TTM	$1,407,250,944
EBITDA	$541,405,000
Net Income to Common TTM	$-778,689,984
Diluted EPS TTM	$-28.09
Quarterly Earnings Growth YoY	514.70%

Balance Sheet

Total Cash MRQ	$1,622,457,984
Total Cash per Share MRQ	$57.95
Total Debt MRQ	$
Total Debt to Equity MRQ	18.54
Current Ratio MRQ	6.14
Book Value per Share MRQ	$267.47

Cash Flow

Operating Cash Flow TTM	$412,000,000
Levered Free Cash Flow TTM	$91,243,872

BIO Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	22,921,900
Float Shares	19,437,314
Avg 10 Volume	163,280
Avg 30 Volume	None
Shares Short	655,521
Short Ratio	3.72
Short % of Shares	3.78%
% Held by Insiders	15.57%
% Held by Institutions	87.75%

Stock Price Summary

Beta	0.94
Fifty Two Week Low	$262.12
Fifty Two Week High	$387.99
Fifty Two Week Change	6.98%
Day 50 MA	$338.34
Day 200 MA	$317.75

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2002-03-08